Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments

Abstract Background The Symptom Screening in Pediatrics Tool (SSPedi) is valid for assessing symptoms in children aged 8–18 years receiving cancer treatments. The objective was to develop a new self-report symptom screening tool for children receiving cancer treatments who are 4–7 years of age (mini...

Full description

Bibliographic Details
Main Authors: Deborah Tomlinson, Shannon Hyslop, Eliana Stein, Brenda Spiegler, Emily Vettese, Susan Kuczynski, Tal Schechter, L. Lee Dupuis, Lillian Sung
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-5210-z
id doaj-919fc3b3325b4b3fa81131f9a0e43ecf
record_format Article
spelling doaj-919fc3b3325b4b3fa81131f9a0e43ecf2020-11-25T01:41:45ZengBMCBMC Cancer1471-24072019-01-011911910.1186/s12885-018-5210-zDevelopment of mini-SSPedi for children 4–7 years of age receiving cancer treatmentsDeborah Tomlinson0Shannon Hyslop1Eliana Stein2Brenda Spiegler3Emily Vettese4Susan Kuczynski5Tal Schechter6L. Lee Dupuis7Lillian Sung8Child Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and LearningChild Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and LearningChild Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and LearningDepartment of Psychology, The Hospital for Sick ChildrenChild Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and LearningOntario Parents Advocating for Children with Cancer (OPACC)Department of Psychology, The Hospital for Sick ChildrenChild Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and LearningChild Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and LearningAbstract Background The Symptom Screening in Pediatrics Tool (SSPedi) is valid for assessing symptoms in children aged 8–18 years receiving cancer treatments. The objective was to develop a new self-report symptom screening tool for children receiving cancer treatments who are 4–7 years of age (mini-SSPedi), based on SSPedi. Methods Respondents were children with cancer or pediatric hematopoietic stem cell transplantation (HSCT) recipients who were 4–7 years of age. We included the same 15 symptoms contained in SSPedi. Using cognitive interviewing, we developed mini-SSPedi in three phases and made decisions based upon respondent understanding. First, we developed questionnaire structure regarding recall period, concept of bother and response option format. Second, we determined wording of each symptom. Third, we evaluated the entire mini-SSPedi instrument for understanding and ease of completion. Results We enrolled 100 participants in total and included 30, 40 and 30 in each of the three phases. Questionnaire structure was satisfactory with a recall period of “today” and a faces-based 3-point Likert scale. Bother was well-understood. Five symptoms required modification to achieve satisfactory understanding while the remaining 10 SSPedi symptoms did not require modification. Among the last 10 children enrolled, all understood each mini-SSPedi item and none thought mini-SSPedi was hard to complete. Conclusion We developed a symptom screening tool for children with cancer and pediatric HSCT recipients between 4 and 7 years of age that is understandable and easy to complete. Future work will evaluate the psychometric properties of mini-SSPedi and develop an electronic version of the instrument.http://link.springer.com/article/10.1186/s12885-018-5210-zSymptom screeningChildrenSelf-reportCancerHematopoietic stem cell transplantation
collection DOAJ
language English
format Article
sources DOAJ
author Deborah Tomlinson
Shannon Hyslop
Eliana Stein
Brenda Spiegler
Emily Vettese
Susan Kuczynski
Tal Schechter
L. Lee Dupuis
Lillian Sung
spellingShingle Deborah Tomlinson
Shannon Hyslop
Eliana Stein
Brenda Spiegler
Emily Vettese
Susan Kuczynski
Tal Schechter
L. Lee Dupuis
Lillian Sung
Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments
BMC Cancer
Symptom screening
Children
Self-report
Cancer
Hematopoietic stem cell transplantation
author_facet Deborah Tomlinson
Shannon Hyslop
Eliana Stein
Brenda Spiegler
Emily Vettese
Susan Kuczynski
Tal Schechter
L. Lee Dupuis
Lillian Sung
author_sort Deborah Tomlinson
title Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments
title_short Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments
title_full Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments
title_fullStr Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments
title_full_unstemmed Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments
title_sort development of mini-sspedi for children 4–7 years of age receiving cancer treatments
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2019-01-01
description Abstract Background The Symptom Screening in Pediatrics Tool (SSPedi) is valid for assessing symptoms in children aged 8–18 years receiving cancer treatments. The objective was to develop a new self-report symptom screening tool for children receiving cancer treatments who are 4–7 years of age (mini-SSPedi), based on SSPedi. Methods Respondents were children with cancer or pediatric hematopoietic stem cell transplantation (HSCT) recipients who were 4–7 years of age. We included the same 15 symptoms contained in SSPedi. Using cognitive interviewing, we developed mini-SSPedi in three phases and made decisions based upon respondent understanding. First, we developed questionnaire structure regarding recall period, concept of bother and response option format. Second, we determined wording of each symptom. Third, we evaluated the entire mini-SSPedi instrument for understanding and ease of completion. Results We enrolled 100 participants in total and included 30, 40 and 30 in each of the three phases. Questionnaire structure was satisfactory with a recall period of “today” and a faces-based 3-point Likert scale. Bother was well-understood. Five symptoms required modification to achieve satisfactory understanding while the remaining 10 SSPedi symptoms did not require modification. Among the last 10 children enrolled, all understood each mini-SSPedi item and none thought mini-SSPedi was hard to complete. Conclusion We developed a symptom screening tool for children with cancer and pediatric HSCT recipients between 4 and 7 years of age that is understandable and easy to complete. Future work will evaluate the psychometric properties of mini-SSPedi and develop an electronic version of the instrument.
topic Symptom screening
Children
Self-report
Cancer
Hematopoietic stem cell transplantation
url http://link.springer.com/article/10.1186/s12885-018-5210-z
work_keys_str_mv AT deborahtomlinson developmentofminisspediforchildren47yearsofagereceivingcancertreatments
AT shannonhyslop developmentofminisspediforchildren47yearsofagereceivingcancertreatments
AT elianastein developmentofminisspediforchildren47yearsofagereceivingcancertreatments
AT brendaspiegler developmentofminisspediforchildren47yearsofagereceivingcancertreatments
AT emilyvettese developmentofminisspediforchildren47yearsofagereceivingcancertreatments
AT susankuczynski developmentofminisspediforchildren47yearsofagereceivingcancertreatments
AT talschechter developmentofminisspediforchildren47yearsofagereceivingcancertreatments
AT lleedupuis developmentofminisspediforchildren47yearsofagereceivingcancertreatments
AT lilliansung developmentofminisspediforchildren47yearsofagereceivingcancertreatments
_version_ 1725039749288165376